PIK3CA and ovarian carcinoma: Two cases with PIK3CA mutation were observed in which 1 patient had best response of PR (breast cancer, PIK3CA mutation at N345K, treatment duration 51 weeks) and another patient had SD (ovarian cancer, PIK3CA mutation at H1047R, treatment duration 16 weeks).